In DLD-1 and HT29 cells, downregulation of AGAP2-AS1 resulted in marked cancer cell growth suppression, cell cycle arrest (at G0/G1 phase) and protein level reduction (p-MEK, p-Raf-1, p-Erk and Ras) [35]. This evidence concerns the gene AGAP2 and cancer.